Home › NCT06377969

Prospective Evaluation of Effectiveness and Safety of Closed-Loop Spinal Cord Stimulation in Treating Patients With Chronic Pelvic Pain

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

The investigators will include all adult patients (18 or older) with pelvic pain more than 6 months that has not responded to conservative medical management

Exclusion Criteria:

* Major untreated medical comorbidities (uncontrolled diabetes mellitus, severe obesity, uncontrolled cardiopulmonary disease, etc.)
* Secondary causes of pelvic pain that can be treated with appropriate medical or surgical interventions
* Major untreated psychological comorbidities
* Anatomical challeneges to place spinal cord stimulator
* Ongoing legal or disability claims

About the study

Spinal cord stimulation (SCS) is an effective treatment for patients with chronic pelvic pain. The investigators will evaluate how safe and effective closed-loop spinal cord stimulation is in treating these patients; closed-loop spinal cord stimulation is a more novel method in delivering spinal cord stimulation that controls energy output of the device based on real-time feedback on how the device is stimulating the spinal cord.

What is being tested

• ECAP (Evoked Compound Action Potential)-controlled Closed-Loop Spinal Cord Stimulation (device)

Sponsor: Stanford University · Participants: 10 · Started: Jun 1, 2025

Contact the study team

• Vafi Salmasi, MD · Phone: 6507250246

Official record on ClinicalTrials.gov — NCT06377969

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.